Skip to main content
Clinical Trials/NCT03251677
NCT03251677
Completed
Not Applicable

A Prospective Randomized Study Comparing Total Laparoscopic Hysterectomy (Lap Hysterectomy) vs Minilaparotomy (Mini-lap Hysterectomy) for Benign Uterine Lesions: Peri-operative Outcome

Mansoura University1 site in 1 country40 target enrollmentSeptember 1, 2017
ConditionsHysteromyoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hysteromyoma
Sponsor
Mansoura University
Enrollment
40
Locations
1
Primary Endpoint
Operative Time (min)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The objective of this study is to compare the perioperative outcomes between mini-lap hysterectomy and total laparoscopic hysterectomy (TLH) because of benign indications.

Detailed Description

A prospective randomized open-label study was conducted. Women \>18 years of age undergoing TLH because of benign indications were recruited. Patients were randomized for either TLH (Group I, 40 cases) or minilap hysterectomy (Group II, 40 cases) through 4-5cm abdominal Pfannenstiel incision. Inclusion criteria were mobile uterus with benign lesion and with a size up to 12 weeks gestation. Exclusion criteria adopted were patients with enlarged uterus \< 12 weeks, suspected malignancy and large adnexal masses (\>5cm). Peri-operative outcomes were compared. Written informed consent was obtained from all the patients and the Departmental Ethical Committee approved the study. Patients from OB/GYN Mansoura University Hospital were enrolled. All the operations were performed by at least one of the consultants included as authors in this study.

Registry
clinicaltrials.gov
Start Date
September 1, 2017
End Date
March 1, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tarek Shokeir

Prof. Obstetrics & Gynecology

Mansoura University

Eligibility Criteria

Inclusion Criteria

  • Mobile uterus.
  • Uterine size up to 12 weeks gestation.
  • Benign lesions.

Exclusion Criteria

  • Enlarged uterus \> 12 weeks gestation.
  • Suspected malignancy.
  • Large adnexal masses.

Outcomes

Primary Outcomes

Operative Time (min)

Time Frame: Intraoperative (Starting with induction of anesthesia (Time 0) up to complete removal of the uterus)

Time in minutes taken for total hysterectomy

Estimated blood loss (mL)

Time Frame: Through surgical intervention completion

Drop of hemoglobin and hematocrit percentage (%) 24-hours from basal pre-operative values

Secondary Outcomes

  • Early postoperative complications(Within 30 days after operation)

Study Sites (1)

Loading locations...

Similar Trials